English | 繁體

Search in the results

UM

Browse/Search Results:  1-5 of 5 Help

Selected(0)Clear Items/Page:    Sort:
Targeting STAT3-VISTA axis to suppress tumor aggression and burden in acute myeloid leukemia Journal article
Mo, Jianshan, Deng, Lin, Peng, Keren, Ouyang, Shumin, Ding, Wen, Lou, Linlin, Lin, Ziyou, Zhu, Jianzheng, Li, Jingwei, Zhang, Qiyi, Wang, Pengyan, Wen, Yuanzhen, Chen, Xiaobing, Yue, Peibin, Lu, Jin Jian, Zhu, Kai, Zheng, Yongjiang, Wang, Yuanxiang, Zhang, Xiaolei. Targeting STAT3-VISTA axis to suppress tumor aggression and burden in acute myeloid leukemia[J]. Journal of Hematology & Oncology, 2023, 16(1), 15.
Authors:  Mo, Jianshan;  Deng, Lin;  Peng, Keren;  Ouyang, Shumin;  Ding, Wen; et al.
Favorite | TC[WOS]:15 TC[Scopus]:14  IF:29.5/26.9 | Submit date：2023/03/06
Aml  Immunotherapy  Stat3 Inhibitor  Vista  
Network pharmacology-based investigation and experimental validation of the mechanism of scutellarin in the treatment of acute myeloid leukemia Journal article
Huang, Zhe, Yang, Yan, Fan, Xianming, Ma, Wenzhe. Network pharmacology-based investigation and experimental validation of the mechanism of scutellarin in the treatment of acute myeloid leukemia[J]. Frontiers in Pharmacology, 2022, 13.
Authors:  Huang, Zhe;  Yang, Yan;  Fan, Xianming;  Ma, Wenzhe
Favorite | TC[WOS]:5 TC[Scopus]:5  IF:4.4/5.0 | Submit date：2023/01/30
Aml  Apoptosis  Jnk/caspase-3 Signal Pathway  Network Pharmacology  Scutellarin  
Higher Expression of WT1 With Lower CD58 Expression may be Biomarkers for Risk Stratification of Patients With Cytogenetically Normal Acute Myeloid Leukemia Journal article
Chen, Cunte, Chen, Zhuowen, Chio, Chi Leong, Zhao, Ying, Li, Yongsheng, Liu, Zhipeng, Jin, Zhenyi, Wei, Wei, Zhao, Qi, Li, Yangqiu. Higher Expression of WT1 With Lower CD58 Expression may be Biomarkers for Risk Stratification of Patients With Cytogenetically Normal Acute Myeloid Leukemia[J]. Technology in cancer research & treatment, 2021, 20, 15330338211052152.
Authors:  Chen, Cunte;  Chen, Zhuowen;  Chio, Chi Leong;  Zhao, Ying;  Li, Yongsheng; et al.
Favorite | TC[WOS]:6 TC[Scopus]:6  IF:2.7/2.8 | Submit date：2022/08/27
Cd58  Cn-aml  Wt1  Biomarker  Risk Stratification  
An Example of using Precision Medicine in Cancer Care: Dynamic Change of TET2 Mutation in a Patient with Therapy-related Myelodysplastic Syndrome/ Acute Myeloid Leukemia Journal article
Chen, P, Kim, Y, Akhtari, M, Wang, S. M.. An Example of using Precision Medicine in Cancer Care: Dynamic Change of TET2 Mutation in a Patient with Therapy-related Myelodysplastic Syndrome/ Acute Myeloid Leukemia[J]. International Journal of Cancer Research and Molecular Mechanisms, 2017, 1-5.
Authors:  Chen, P;  Kim, Y;  Akhtari, M;  Wang, S. M.
Favorite |  | Submit date：2022/07/27
Exome sequencing  Somatic mutation  tMDS/AML  TET2  
An Example of using Precision Medicine in Cancer Care: Dynamic Change of TET2 Mutation in a Patient with Therapy-related Myelodysplastic Syndrome/Acute Myeloid Leukemia Journal article
Peixian Chen, Yeong C Kim, Mojitaba Akhtari, San Ming Wang. An Example of using Precision Medicine in Cancer Care: Dynamic Change of TET2 Mutation in a Patient with Therapy-related Myelodysplastic Syndrome/Acute Myeloid Leukemia[J]. International Journal of Cancer Research and Molecular Mechanisms, 2017, 3(2).
Authors:  Peixian Chen;  Yeong C Kim;  Mojitaba Akhtari;  San Ming Wang
Favorite | TC[Scopus]:0 | Submit date：2018/12/18
Exome Sequencing  Somatic Mutation  Tmds/aml  Tet2